PROSTATE CANCER AND PROSTATIC DISEASES

简称 PROSTATE CANCER P D ·ENGLAND ·出版周期 Quarterly ·年均收录 64 篇

5.8

最新影响因子

3.60%

自引率

较易

投稿难度

较慢,6-12周

审稿周期

期刊简介

《Prostate Cancer and Prostatic Diseases》是一本专注于前列腺癌和前列腺疾病的国际学术期刊，ISSN号为1365-7852，由Springer Nature出版，出版地为英国，出版周期为季刊。该期刊被SCI收录，2022年影响因子为4.8，属于中科院医学大类三区，非开放获取（OA）期刊。其发文特点集中于前列腺癌的基础与临床研究，涵盖流行病学、分子机制、诊断技术、治疗策略及患者生活质量等领域，尤其关注多学科交叉研究和转化医学应用。杂志质量较高，审稿严格，但作为专科期刊，读者群体相对局限，且近年竞争加剧可能导致投稿难度上升，需注意研究创新性与临床相关性以提升录用率。

影响因子趋势

近期发表

Re-evaluating the long-term efficacy and safety of the Zenflow spring system: insights from a multidisciplinary perspective 2026-09-16

Beyond nuclear AR-V7: rethinking subcellular localization as a dynamic biomarker of endocrine resistance in mCRPC 2026-09-14

Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer 2026-09-05

Oncological and functional outcomes of focal irreversible electroporation for localised prostate cancer: a single institution series of 171 cases 2026-09-01

Prostate size and its effect on sexual function following convective water vapor thermal therapy 2026-08-24

Correlation of intraprostatic lesional SUVmax during PSMA PET/CT and adverse pathology at radical prostatectomy 2026-08-24

Successful cabazitaxel desensitization after severe taxane hypersensitivity reactions: a brief report 2026-08-21

Correspondence: persistence, progression, and PSA: what exactly does DEAR-EXT compare? Yanping Zhu, Xiaohui Wang, Yang Zhang, Shuangwu Lv 2026-08-18

Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States 2026-08-14

Beyond the Scalpel: how the PROTEUS trial redefines the role of the radical prostatectomy 2026-08-12